UniTox: Leveraging LLMs to Curate a Unified Dataset of Drug-Induced Toxicity from FDA Labels
Open accessAbstract
Drug-induced toxicity is one of the leading reasons new drugs fail clinical trials. Machine learning models that predict drug toxicity from molecular structure could help researchers prioritize less toxic drug candidates. However, current toxicity datasets are typically small and limited to a single organ system (e.g., cardio, renal, or liver). Creating these datasets often involved time-intensive expert curation by parsing drug label documents that can exceed 100 pages per drug. Here, we introduce UniTox 1 , a unified dataset of 2,418 FDA-approved drugs with drug-induced toxicity summaries and ratings created by using GPT-4o to process FDA drug labels. UniTox spans eight types of toxicity: cardiotoxicity, liver toxicity, renal toxicity, pulmonary toxicity, hematological toxicity, dermatological toxicity, ototoxicity, and infertility. This is, to the best of our knowledge, the largest such systematic human in vivo database by number of drugs and toxicities, and the first covering nearly all FDA-approved medications for several of these toxicities. We recruited clinicians to validate a random sample of our GPT-4o annotated toxicities, and UniTox’s toxicity ratings concord with clinician labelers 87–96% of the time. Finally, we benchmark a graph neural network trained on UniTox to demonstrate the utility of this dataset for building molecular toxicity prediction models.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
To date, no public dataset has systematically annotated or categorized extrapolation decisions in FDA drug labels.
“to date, no public dataset has systematically annotated or categorized extrapolation decisions in FDA drug labels.”
From PED-X-Bench: A Benchmark of Adult-to-Pediatric Extrapolation Decisions in FDA Drug Labels (2025) · cites this paper as [12]
Recent NLP work on FDA labels targets toxicity or adverse-event extraction or general summarisation, not extrapolation.
“recent NLP work on FDA labels targets toxicity or adverse-event extraction [12, 13] or general summarisation [14], not extrapolation.”
From PED-X-Bench: A Benchmark of Adult-to-Pediatric Extrapolation Decisions in FDA Drug Labels (2025) · cites this paper as [12]
Cited by
Sorted by citations
Wu, L., Fang, H., Qu, Y., Xu, J., & Tong, W. (2025) · Drug Safety · doi:10.1007/s40264-025-01520-1 · Cited by 20 · see citing works
“These datasets have spurred numerous artificial intelligence (AI)/machine learning initiatives on drug toxicity prediction [14–18].”
PED-X-Bench: A Benchmark of Adult-to-Pediatric Extrapolation Decisions in FDA Drug Labels
Srinivasan, A., Berkowitz, J., Friedrich, N. A., Tsang, K., Kuchi, A., Acitores, J., Zietz, M., Czarny, R. S., Liu, H., & Tatonetti, N. P. (2025) · medRxiv · doi:10.1101/2025.05.22.25328187
“On the other hand, recent NLP work on FDA labels targets toxicity or adverse-event extraction [12, 13] or general summarisation [14], not extrapolation.”
- Authors
- Silberg, J., Swanson, K., Simon, E., Zhang, A., Ghazizadeh, Z., Ogden, S., Hamadeh, H., & Zou, J.
- Affiliations
- Stanford University (US)
- Genmab (United States) (US)
- Corresponding author
- Silberg, Jake
- Venue
- neural information processing systems
- Publisher
- openRxiv
- Published
- 2024-06-22
- Pages
- 12078-12093
- ISSN
- 1049-5258 (ISSN-L)
- OpenAlex
- W4415798795
- Cited by
- 9
- References
- 0
- Citations by year
- 2026: 2 · 2025: 7
- FWCI
- 18.10
- Type
- conference paper
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nd
- Locations
- neural information processing systems (publishedVersion)
- medRxiv (acceptedVersion, cc-by-nd)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biomedical Text Mining and Ontologies
- Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
- Keywords
- drug toxicity, FDA drug labels, large language models, adverse drug reactions, drug safety
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review